Why he matters in this case
Prof. Yeh’s signature on the Panel report brings the East Asian neonatology perspective. The Taiwanese neonatal system operates broadly equivalent clinical protocols to Western systems, and has produced substantial peer-reviewed research on preterm-lung development — research that informs how a modern neonatologist reads respiratory-component collapses in preterm infants.
Professional background
- Professor Emeritus of Paediatrics, Taiwan.
- Long peer-reviewed publication record in neonatal respiratory distress syndrome, bronchopulmonary dysplasia, and steroid therapy protocols.
- Member of the Shoo Lee International Expert Panel.
Why an Asian signatory matters
One of the Panel’s strengths is geographical breadth. A finding endorsed by neonatologists from North America, Europe, Oceania and Asia is harder to dismiss as the view of one school of clinical practice. Prof. Yeh’s signature is part of that geographical coherence.
The neonatal-respiratory perspective
Prof. Yeh’s research career has focused on the respiratory complications of preterm birth: neonatal respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and the role of antenatal and postnatal steroid therapy in preterm-lung maturation. The relevance to the Letby case is that the deteriorations described in several indicted cases involved respiratory components — sudden desaturations, apnoeic episodes, oxygen-requirement changes — and modern neonatologists read these against a documented baseline distribution of natural-cause respiratory instability that is gestation-specific.
Prof. Yeh’s contribution to the Panel methodology is the East-Asian clinical-research perspective on these baseline distributions. Taiwanese neonatal-intensive-care research is published in the same English-language peer-reviewed journals (Pediatrics, Journal of Pediatrics, Acta Paediatrica) and uses comparable clinical protocols to UK and North American practice. His sign-on adds a non-Western institutional voice to the Panel finding without introducing methodological asymmetry.
What an Asian signatory contributes structurally
The Panel’s legitimacy rests in part on its breadth. A 14-strong panel with signatories from Canada, the UK, Sweden, Germany, Belgium, the Netherlands, New Zealand, Australia, the United States and Taiwan cannot be dismissed as the parochial view of one national clinical school. Prof. Yeh’s contribution is that institutional-breadth element. The unanimity of the Panel finding across this geographical span is one of the load-bearing features of the February 2025 report’s evidential weight.
Clinical neonatology background and research career
Prof. Yeh’s clinical and academic career spans several decades of neonatal intensive care practice. His published research focuses principally on the management of respiratory complications in preterm neonates: neonatal respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and the use of antenatal and postnatal corticosteroid therapy to accelerate lung maturation. These are among the most common serious complications of preterm birth, and the clinical knowledge base that Prof. Yeh brings to the Panel specifically addresses how preterm respiratory physiology contributes to the risk of acute deterioration.
For the purposes of the Panel’s methodology, the neonatal-respiratory perspective matters because the deterioration patterns in several indicted cases involved respiratory components — sudden oxygen desaturation, apnoeic episodes, changes in ventilator requirement — that a neonatologist with Prof. Yeh’s background reads against a documented distribution of natural-cause respiratory instability that is specific to gestational age and clinical condition. An infant at 23 or 26 weeks’ gestation is not assessed against the same baseline respiratory stability expectation as a term infant; the clinical literature that Prof. Yeh has contributed to quantifies these gestational-age-specific baseline rates.
Role in the 14-member Panel
The Shoo Lee International Expert Panel comprised fourteen senior neonatologists drawn from ten countries across four continents. Prof. Yeh is one of the Asian signatories to the Panel report, providing the Taiwanese clinical-research perspective alongside colleagues from North America, Europe, and Oceania. The Panel operated by case-by-case review: each member reviewed the clinical record for each indicted infant, applying their own clinical judgment and the Panel’s agreed methodological framework, before the group reached a collective finding.
A fourteen-strong Panel with no single signatory drawn from England and Wales is a deliberate structural design choice by Panel convenor Dr Shoo Lee: it insulates the clinical findings from accusations of domestic-agenda influence. Prof. Yeh’s participation contributes to that insulation by anchoring the Panel’s findings in the neonatal clinical literature from a jurisdiction with no institutional stake in the outcome of the English prosecution.
Canadian neonatal-network context
Prof. Yeh has worked within the broader Pacific Rim neonatal-research network, which includes close connections with Canadian neonatal-intensive-care research. Canada operates one of the most rigorously documented national neonatal datasets in the world — the Canadian Neonatal Network (CNN) — which produces peer-reviewed outcome statistics for preterm infants at specific gestational ages and clinical risk categories. These benchmark datasets are the kind of evidence base against which a neonatologist assesses whether a particular cluster of deteriorations in a particular gestational range is statistically expected or anomalous. The Panel’s conclusion that the deteriorations in the indicted cases fall within expected clinical parameters is supported by this kind of comparative statistical grounding, to which researchers embedded in the Pacific Rim and Canadian neonatal-research networks have direct access.